Overview

A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of different dose regimens of Ceftaroline
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Pfizer
Treatments:
Ceftaroline fosamil
Cephalosporins